Drug Shortage Report for KEVZARA
Report ID | 188465 |
Drug Identification Number | 02460548 |
Brand name | KEVZARA |
Common or Proper name | KEVZARA 200 |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | SARILUMAB |
Strength(s) | 200MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 2 |
ATC code | L04AC |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-03-31 |
Estimated end date | 2023-04-10 |
Actual end date | 2023-04-04 |
Shortage status | Resolved |
Updated date | 2023-04-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-03-31 | English | Compare |
v2 | 2023-03-31 | French | Compare |
v3 | 2023-04-01 | English | Compare |
v4 | 2023-04-04 | English | Compare |
v5 | 2023-04-04 | French | Compare |
Showing 1 to 5 of 5